Brain natriuretic peptide is proposed as a biochemical marker which could p
rovide a useful screening test to select patients for further cardiac inves
tigations in heart failure. The applicability of such a biochemical test in
clinics, hospital wards, and clinical laboratories is dependent on its eas
e of use and on the complexity of sample handling. The present study was un
dertaken to evaluate the stability of brain natriuretic peptide under a num
ber of different handling conditions (sample collection, storage temperatur
es, freezing temperatures) assayed with a commercially available kit. The r
esults clearly demonstrate that brain natriuretic peptide is stable at room
temperature far 24 hours, or in up to 30 degrees C for 12 hours in the pre
sence and absence of aprotinin, on the condition that brain natriuretic pep
tide is assayed within one month (frozen at -20 degrees C) after blood coll
ection. The presence of aprotinin prevents brain natriuretic peptide degrad
ation in samples preserved for more than 1 month at -20 degrees C before as
say.